Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Friday evening:
Invitae (NVTA) : "If you want targeted cancer treatments, this one is a buy."
ComScore (SCOR) : "I don't want to touch it, they don't have the growth I need."
Dominion Energy (D) : "These guys are fantastic."
E*TRADE Financial (ETFC) : "This one is tougher for me to recommend."
Exact Sciences (EXAS) : "I would hold onto this one. It's doing quite well."
Cramer and the AAP team are looking at how end-of-the-year market volatility is affecting their portfolio. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
Over on Real Money, Cramer is calling it like it is, and sharing his perspective on the markets. Get more of his insights with a free trial subscription to Real Money.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.